This study aimed to assess the relationship between FGF23 and the risk of cardiovascular diseases (CVDs) in general populations.<h4>Methods</h4>The protocol was registered prospectively in PROSPERO (CRD42021281837) and two authors independently searched for relevant studies in the PubMed, EMBASE, and Cochrane Library databases. The gene discussed is FGF23; the disease is cardiovascular disorder.